Acadia Healthcare (NASDAQ:ACHC) Given New $44.50 Price Target at Bank of America

Acadia Healthcare (NASDAQ:ACHC) had its price target lowered by Bank of America from $50.00 to $44.50 in a research note published on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

Other equities analysts have also issued reports about the stock. KeyCorp raised shares of Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price target on the stock in a research report on Tuesday, January 7th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $64.00 price target on shares of Acadia Healthcare in a research report on Friday, January 10th. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Barclays lowered shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price target for the stock from $43.00 to $35.00 in a research report on Friday. Finally, TD Cowen lowered their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $59.56.

Acadia Healthcare Price Performance

Shares of ACHC opened at $29.98 on Friday. The firm has a market capitalization of $2.78 billion, a PE ratio of 9.83, a PEG ratio of 1.46 and a beta of 1.30. The company’s 50-day moving average is $42.10 and its 200-day moving average is $51.93. Acadia Healthcare has a fifty-two week low of $29.79 and a fifty-two week high of $86.56. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Institutional Investors Weigh In On Acadia Healthcare

A number of large investors have recently bought and sold shares of ACHC. Treasurer of the State of North Carolina boosted its stake in shares of Acadia Healthcare by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company’s stock valued at $1,586,000 after purchasing an additional 250 shares in the last quarter. Nisa Investment Advisors LLC boosted its stake in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after purchasing an additional 301 shares in the last quarter. Coldstream Capital Management Inc. boosted its stake in shares of Acadia Healthcare by 4.9% in the 4th quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company’s stock valued at $257,000 after purchasing an additional 303 shares in the last quarter. Atria Investments Inc boosted its stake in shares of Acadia Healthcare by 4.7% in the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after purchasing an additional 308 shares in the last quarter. Finally, Covestor Ltd boosted its stake in shares of Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company’s stock valued at $58,000 after purchasing an additional 310 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.